GPS for Your Health: Unleashing Real-Time Biochemistry Data to Empower Healthy Decisions From the Clinic to the Home
ABSTRACT
The vision of having real-time information from one’s body to enable better decisions around health and disease management has been around for a couple of decades. While this goal is clearly valuable and technically feasible, much of the efforts in this area has under-performed relative to their potential. In this talk, we’ll discuss the potential reasons for the delay in realizing this important ambition. We will also offer thoughts and potential technical solutions that will align the advancements made in technology and their application to the health care arena. Through the innovations of injected microsensors, technology that enables real-time, on-demand, clinically accurate and validated biochemistry data is here. Leveraging the latest advancements in micro-electronics, advanced bio-materials, biology and physiology, and machine learning analytics, we are able to finally deliver on the promise of personalized health information like never before. Lastly, we will discuss the future applications and the enablement of this technology to get us closer than ever to that vision.
BIOGRAPHY
From his early exposure as an undergraduate research fellow at the lab of Leroy Hood at Caltech, where the automated DNA sequencer was developed, to bringing cutting edge life sciences tools to the market at Life Technologies Corp. (acquired by Thermo Fisher Scientific, Inc.), Ben has seen first-hand the transformative impact that science and technology have to change our world. Prior to Profusa, Ben served in a variety of leadership roles at Life Technologies Corp., including President of the Asia Pacific Region and Head of the qPCR Division. A former management consultant at McKinsey and Company, Ben earned his M.A. and Ph.D. in Biology from The Johns Hopkins University.